Although tumor lysis syndrome is well described after chemotherapy for non-solid tumors, it is rarely seen or suspected in solid malignancies. Early recognition of this condition is paramount to reduce morbidity and mortality.
Introduction
Tumor lysis syndrome (TLS) is a well described oncologic emergency. The syndrome is deemed spontaneous when it occurs before initiation of any cytotoxic or definitive treatment. Here, we report the rare case of a 70-year old man with colon cancer and extensive liver involvement manifesting with TLS following surgery. Previous investigators had demonstrated only fourteen cases with TLS associated in colorectal cancer [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . Ten of the fourteen cases were induced by chemotherapy, three were spontaneous tumor lysis syndrome (STLS), and one was induced by radiofrequency ablation (RFA). This is therefore the first report of TLS induced by surgery in case of colon cancer with liver metastases.
Case Presentation
A 70-year old Japanese man, who had been in good health until two months prior to this admission, presented with worsening abdominal pain, accompanied by loss of appetite, fever and subjective weight loss. The patient also (Table 1) . Kidneys ultrasound showed normal renal parenchyma with no evidence of obstructive uropathy. We diagnosed this as TLS. All available supportive measures, including continuous hemodiafiltration, were initiated from 1 to 7 postoperative days. Then, the patient also experienced liver failure and disseminated intravascular coagulation (DIC) from 3 to 11 postoperative days ( Table 1 ). The patient subsequently recovered from TLS, and was administered the anticancer-drugs (FOLFOX) on postoperative day 21. 
Discussion
We present here the first case of TLS as a complication after surgery for metastatic colon adenocarcinoma. TLS is an oncological emergency precipitated by massive release into the circulation of intracellular tumor contents, [6] .
In most patients, TLS occurs as a result of chemotherapy, however, it may also be induced by other anti-neoplastic treatments, including radiotherapy, hormone therapy and immunotherapy, or may develop spontaneously before initiation of therapy [16, 17] . STLS is defined as the TLS occurring in the absence of any definitive treatment [18] .
The incidence of STLS in solid tumor is rare. The first step for TLS diagnosis is based on the laboratory findings in an appropriate clinical context. Hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia are the primary indicators of TLS [15, 16] . Clinical TLS is considered when traditional laboratory findings are accompanied by diarrhea, nausea, vomiting, lethargy, cardiac arrhythmias, seizures, or sudden death [17, 18] . Patient care when TLS has been established should include astute monitoring of uric acid, potassium, phosphorous, calcium, lactate dehydrogenase and serum creatinine levels, alongside cardiac monitoring and monitoring urine output. Allopurinol may be a useful prophylactic to lower uric acid production in patients at risk of TLS. However, allopurinol use may result in elevated xanthine levels by inhibiting xanthine oxidase in patients with TLS [19] [20] [21] . Xanthine may also precipitate in the renal tubules, contributing to obstructive uropathy in a similar manner as uric acid [20, 21] . As a result, rasburicase, which converts uric acid to soluble allantoin, is the recommended drug for hyperuricemia in TLS [15, 16, 18, 19] . The dialysis need to be initiated for hyperkalemia, hyperphosphatemia, or hypocalcemia [15] . The present case was not treated with rasburicase, due to a sufficient decrease in uric acid by the second postoperative day through continuous hemodiafiltration.
The first reported case of TLS in a nonhematological malignancy occurred in 1977 [22] . Approximately 120-140
reported cases of tumor lysis in solid tumors have since been reported, mostly after treatment, between 1977 and 
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2018 [6, 19] . Although there was different origins of primary tumors, extensive liver involvement has been noted in 82.8% of all cases. When the liver was not involved, patients inevitably had a large tumor burdens accompanied by necrosis. As noted by Gemici et al. [16] , liver involvement seems to predispose patients to the TLS. This may be due to a high purine pool in the liver, which may be released during necrosis, or due to impaired uric acid metabolism if hepatic function is impaired by a high tumor burden [16] . TLS in solid tumors is unpredictable and carries a worse prognosis when compared to hematological malignancies [16] . Mortality rates are 20%-50% across all cases of TLS in solid tumors if undiagnosed or if diagnosed too late [19, 23] .
Our literature review of TLS in patients with colon cancer revealed only three cases of STLS, ten of tumor lysis induced by a chemotherapy, one of tumor lysis induced by RFA, and the present case of tumor lysis induced by surgery [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] ( 
